Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.06B |
| 2 |
Amazon
AMZN
|
+$1.51B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.42B |
| 4 |
Tesla
TSLA
|
+$1.17B |
| 5 |
Microsoft
MSFT
|
+$997M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SJR
Shaw Communications Inc.
SJR
|
+$925M |
| 2 |
iShares MSCI ACWI ETF
ACWI
|
+$724M |
| 3 |
Eaton
ETN
|
+$581M |
| 4 |
Uber
UBER
|
+$538M |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$510M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.98% |
| 2 | Healthcare | 10.48% |
| 3 | Financials | 9.86% |
| 4 | Consumer Discretionary | 8.78% |
| 5 | Industrials | 6.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4751
Hippo Holdings
HIPO
$852M
| $929K | ﹤0.01% |
56,203
+25,766
| +85% | +$447K |
|
4752
Cooper-Standard Automotive
CPS
$553M
| $929K | ﹤0.01% |
65,124
+2,601
| +4% | +$31.7K |
|
|
KLRS
4753
Kalaris Therapeutics
KLRS
$99.7M
| $926K | ﹤0.01% |
11,845
+3,722
| +46% | +$354K |
|
4754
Byline Bancorp
BY
$1.8B
| $925K | ﹤0.01% |
51,157
+17,359
| +51% | +$326K |
|
|
LOGC
4755
DELISTED
ContextLogic
LOGC
| $923K | ﹤0.01% |
140,252
+97,689
| +230% | +$774K |
|
|
IGMS
4756
DELISTED
IGM Biosciences
IGMS
| $922K | ﹤0.01% |
99,936
+18,252
| +22% | +$204K |
|
4757
Invesco Oil & Gas Services ETF
PXJ
$61.4M
| $921K | ﹤0.01% |
37,068
-236,636
| -86% | -$5.66M |
|
4758
Sportradar
SRAD
$3.7B
| $921K | ﹤0.01% |
71,375
+61,128
| +597% | +$737K |
|
|
GGT
4759
Gabelli Multimedia Trust
GGT
$174M
| $920K | ﹤0.01% |
141,975
+12,259
| +9% | +$71.9K |
|
4760
Safe Bulkers
SB
$781M
| $912K | ﹤0.01% |
279,893
-409,207
| -59% | -$1.44M |
|
|
MTLS
4761
Materialise
MTLS
$394M
| $910K | ﹤0.01% |
105,364
+51,015
| +94% | +$441K |
|
4762
Business First Bancshares
BFST
$1.04B
| $910K | ﹤0.01% |
60,364
-14,267
| -19% | -$220K |
|
4763
HF Foods Group
HFFG
$78.1M
| $910K | ﹤0.01% |
193,945
-9,130
| -4% | -$35.7K |
|
4764
Luxfer Holdings
LXFR
$458M
| $906K | ﹤0.01% |
63,637
+27,951
| +78% | +$428K |
|
4765
Nektar Therapeutics
NKTR
$2.44B
| $905K | ﹤0.01% |
104,908
-18,254
| -15% | -$195K |
|
4766
Tarsus Pharmaceuticals
TARS
$2.65B
| $905K | ﹤0.01% |
50,081
+17,886
| +56% | +$284K |
|
4767
Crawford & Co Class A
CRD.A
$626M
| $903K | ﹤0.01% |
81,413
-1,934
| -2% | -$18.6K |
|
|
TARO
4768
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $899K | ﹤0.01% |
23,700
-21,475
| -48% | -$674K |
|
4769
Teucrium Wheat Fund
WEAT
$297M
| $899K | ﹤0.01% |
27,909
-3,463
| -11% | -$114K |
|
4770
WisdomTree Trust WisdomTree Emerging Markets Quality Dividend Growth Fund
DGRE
$147M
| $898K | ﹤0.01% |
39,440
+1,900
| +5% | +$42.7K |
|
4771
WhiteHorse Finance
WHF
$142M
| $898K | ﹤0.01% |
69,971
+27,885
| +66% | +$340K |
|
|
TVRD
4772
Tvardi Therapeutics
TVRD
$18.8M
| $893K | ﹤0.01% |
8,762
-1,794
| -17% | -$247K |
|
4773
Townsquare Media
TSQ
$115M
| $891K | ﹤0.01% |
74,845
+8,483
| +13% | +$82.7K |
|
4774
Compugen
CGEN
$217M
| $887K | ﹤0.01% |
778,376
-13,821
| -2% | -$12K |
|
|
YMAB
4775
DELISTED
Y-mAbs Therapeutics
YMAB
| $887K | ﹤0.01% |
130,622
-119,827
| -48% | -$898K |
|
Similar funds
Morgan Stanley's Q2 2023 Portfolio in Review
As of Q2 2023, Morgan Stanley held 7,861 positions worth $1.01T, up 8.8% from $933B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Trading was light in Q2 2023: portfolio turnover was 4.8%. Morgan Stanley opened 173 new positions and exited 203, leaving the 7,861-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
- Morgan Stanley's largest Q2 2023 buy was Global X Emerging Markets Great Consumer ETF: 3,490,516 shares worth $87.1M.
- Morgan Stanley added most to NVIDIA in Q2 2023, an estimated $2.06B increase.
- Morgan Stanley's biggest Q2 2023 reduction was iShares MSCI ACWI ETF, cutting an estimated $724M.
- Morgan Stanley fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $925M.
- Morgan Stanley's ten largest holdings make up 18% of its $1.01T portfolio in Q2 2023.
- Morgan Stanley opened 173 new positions and closed 203 in Q2 2023.
- Morgan Stanley's portfolio value rose 8.8% quarter-over-quarter to $1.01T.
Based on Morgan Stanley's 13F filing for Q2 2023, filed 14 Aug 2023.